Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mesenchymal Stem Cell Therapy for the Treatment of Severe or Refractory Inflammatory and/or Autoimmune Disorders

NCT01540292 is registered in ClinicalTrials.gov with University of Liege as lead sponsor.

NCT NCT01540292
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01540292 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mesenchymal Stem Cell Therapy for the Treatment of Severe or Refractory Inflammatory and/or Autoimmune Disorders
Lead sponsor
University of Liege
Phase
Phase 1/2
Overall status
Terminated
Start date
February 1, 2013
Completion date
December 31, 2015
Enrollment
13 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

crohn's disease